Pharmaceutical Industry Business Outlook and Procurement Report H1 2016
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The key priorities forecast in the business structure for global pharmaceutical industry executives in H1 2016 (April–September 2016) are new product development and improving operational efficiency. China, India, and Brazil are the leading emerging markets that are expected to offer the most opportunities for global pharmaceutical industry growth in H1 2016. Market uncertainty and rising competition are the immediate business concerns for global pharmaceutical industry executives. The gradual slowdown and restructuring of economic activity in China and tightening of the monetary policy in the US are creating a major concern for the pharmaceutical industry. Packaging equipment is expected to offer significant growth opportunities within the pharmaceutical industry in Asia-Pacific. Avoidance of counterfeiting and provision of longer shelf life are identified as the key drivers for pharmaceutical packaging companies to witness significant business opportunities within the Asia-Pacific region.
Scope
• The top three key priorities for H1 2016 (April–September 2016) as identified by respondents include new product development, improving operational efficiency, and expansion in current market
• Developed markets such as the US, the UK, and Japan are identified as important regions for growth over the next six months by pharmaceutical respondents
• New product development and IT infrastructure development will record a significant increase or notable increase in capital expenditure over the next six months
• Overall, 52% of executives operating in Europe assigned high preference for outright purchase of pharmaceutical equipment
• In Asia-Pacific, executives forecast packaging equipment and process equipment will offer significant revenue growth opportunities within the pharmaceutical industry.
Reasons to Buy
Highlights key business priorities thus helping pharmaceutical companies to realign business strategy
Develop or adjust business expansion plans by using significant growth opportunities offered by key emerging and developed markets
Make changes in procurement budget allocations through procurement budget projections anticipated by executives for April–September 2016
Helps to alter investment allocation by understanding key focus areas highlighted by survey respondents during H1 2016
Enables organizations to make key decisions on purchase preferences and investments in pharmaceutical equipment.
DiCE Molecules
Juno Therapeutics
WuXi AppTec
Mankind Pharma
Eagle Pharmaceuticals
Albany Molecular Research Inc. (AMRI)
Mylan
Meda Aktiebolag
Cipla
Exelan Pharmaceuticals Inc.
InvaGen Pharmaceuticals Inc
Johnson & Johnson
Tesaro Inc.
Aurobindo
Table of Contents
Table
Figures
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.